Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Vets urged to vaccinate rabbits against RHD-2
RHD2 is a devastating disease that is highly fatal to unvaccinated rabbits.

British Rabbit Council shares its concerns

Vets are being urged to make rabbit hemorrhagic disease type 2 vaccine (RHD-2) part of their core rabbit vaccination programme.

In a letter to Vet Record (Vol 181 No 19), Sarah Elliott of the British Rabbit Council and Richard Saunders of the Rabbit Welfare Association
share their concerns that some vets are telling owners that vaccination is not required.

They write: ‘We have been concerned to hear that, following breeders recommending that newly acquired pet rabbits are taken to their vet for vaccination, some owners are being told that this is not necessary.

‘A recurring conversation at rabbit shows and on public social media has been that pet rabbit owners know nothing about RHD-2 despite having their rabbits vaccinated yearly against myxomatosis and RHD-1.

‘We would also ask that if a breeder approaches a vet to source and provide vaccine for them that you assist with this. Some breeders have a large number of rabbits and we would ask that you offer a site visit to vaccinate their stock.’

RHD2 is a devastating disease that is highly fatal to rabbits that have not been vaccinated. Since it's discovery in the UK in 2010, the disease has spread throughout much of the country and is now more dominant than RHD-1.

In October 2016, following concerns over a lack of vaccine, the European Medicines Agency issued a marketing authorisation for the vaccine ERAVAC to reduce mortality. This was later followed by Filavic, which received its UK licence in April 2017.

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.